BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25567512)

  • 1. Construction and evaluation of a fluorescence-based live attenuated Escherichia coli delivery system for generating oral vaccine candidate.
    Liu W; Li X; Bao J; Guan W; Zhao Z; Yuan C; Tang J; Shi D
    Appl Microbiol Biotechnol; 2015 May; 99(9):4005-18. PubMed ID: 25567512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an attenuated strain oral vaccine candidate using a novel double selection platform in Escherichia coli.
    Liu W; Yuan C; Bao J; Guan W; Zhao Z; Li X; Tang J; Li D; Shi D
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):855-67. PubMed ID: 25301580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression fusion immunogen by live attenuated Escherichia coli against enterotoxins infection in mice.
    Feng N; Guan W
    Microb Biotechnol; 2019 Sep; 12(5):946-961. PubMed ID: 31210426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous oral immunization of mice with live attenuated Escherichia coli expressing LT192-STa 13 and LT 192-STb fusion immunogen, respectively, for polyvalent vaccine candidate.
    Liu W; Li J; Bao J; Li X; Guan W; Yuan C; Tang J; Zhao Z; Shi D
    Appl Microbiol Biotechnol; 2015 May; 99(9):3981-92. PubMed ID: 25549617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Escherichia coli strains expressing the colonization factor antigen I (CFA/I) and a detoxified heat-labile enterotoxin (LThK63) enhance clearance of ETEC from the lungs of mice and protect mice from intestinal ETEC colonization and LT-induced fluid accumulation.
    Byrd W; Boedeker EC
    Vet Immunol Immunopathol; 2013 Mar; 152(1-2):57-67. PubMed ID: 23122616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
    Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
    Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
    Ruan X; Zhang W
    Vaccine; 2013 Mar; 31(11):1458-63. PubMed ID: 23375979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.
    Lundgren A; Leach S; Tobias J; Carlin N; Gustafsson B; Jertborn M; Bourgeois L; Walker R; Holmgren J; Svennerholm AM
    Vaccine; 2013 Feb; 31(8):1163-70. PubMed ID: 23306362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice against enterotoxigenic E. coli by immunization with a polyvalent enterotoxin comprising a combination of LTB, STa, and STb.
    You J; Xu Y; He M; McAllister TA; Thacker PA; Li X; Wang T; Jin L
    Appl Microbiol Biotechnol; 2011 Mar; 89(6):1885-93. PubMed ID: 21085949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.
    Luo Q; Vickers TJ; Fleckenstein JM
    Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X; Liu M; Casey TA; Zhang W
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization with attenuated Salmonella vaccine expressing Escherichia coli O157:H7 intimin gamma triggers both systemic and mucosal humoral immunity in mice.
    Oliveira AF; Cardoso SA; Almeida FB; de Oliveira LL; Pitondo-Silva A; Soares SG; Hanna ES
    Microbiol Immunol; 2012 Aug; 56(8):513-22. PubMed ID: 22671942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenic properties of trivalent recombinant protein composed of B-subunits of LT, STX-2, and CT toxins.
    Kazemi R; Akhavian A; Amani J; Salimian J; Motamedi MJ; Mousavi A; Jafari M; Salmanian AH
    Microbes Infect; 2016 Jun; 18(6):421-429. PubMed ID: 26970204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and immunogenicity of a single oral dose of recombinant double mutant heat-labile toxin derived from enterotoxigenic Escherichia coli.
    El-Kamary SS; Cohen MB; Bourgeois AL; Van De Verg L; Bauers N; Reymann M; Pasetti MF; Chen WH
    Clin Vaccine Immunol; 2013 Nov; 20(11):1764-70. PubMed ID: 24049109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
    Zhang C; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined vaccine regimen based on parenteral priming with a DNA vaccine and administration of an oral booster consisting of a recombinant Salmonella enterica serovar Typhimurium vaccine strain for immunization against infection with human-derived enterotoxigenic Escherichia coli strains.
    Lásaro MO; Luiz WB; Sbrogio-Almeida ME; Nishimura LS; Guth BE; Ferreira LC
    Infect Immun; 2004 Nov; 72(11):6480-91. PubMed ID: 15501779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen.
    Katz DE; DeLorimier AJ; Wolf MK; Hall ER; Cassels FJ; van Hamont JE; Newcomer RL; Davachi MA; Taylor DN; McQueen CE
    Vaccine; 2003 Jan; 21(5-6):341-6. PubMed ID: 12531630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
    Barry EM; Wang J; Wu T; Davis T; Levine MM
    Vaccine; 2006 May; 24(18):3727-34. PubMed ID: 16169130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice protected by oral immunization with Lactobacillus reuteri secreting fusion protein of Escherichia coli enterotoxin subunit protein.
    Wu CM; Chung TC
    FEMS Immunol Med Microbiol; 2007 Aug; 50(3):354-65. PubMed ID: 17651125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.